¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦ 26ȸ »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿¬¼ö°­ÁÂ: ¹ÙÀÌ¿À Ä¡·áÁ¦ÀÇ µ¿Çâ ¹× ¹Ì·¡ : 2023-08-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦ 26ȸ »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿¬¼ö°­ÁÂ: ¹ÙÀÌ¿À Ä¡·áÁ¦ÀÇ µ¿Çâ ¹× ¹Ì·¡ : 2023-08-24
±³À°ÀÏÀÚ : 2023-08-24
±³À°Àå¼Ò : ¼­¿ï¼º¸ðº´¿ø ÀÇ»ý¸í»ê¾÷¿¬±¸¿ø ´ë°­´ç

±³À°ÁÖÁ¦ : Á¦ 26ȸ »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿¬¼ö°­ÁÂ: ¹ÙÀÌ¿À Ä¡·áÁ¦ÀÇ µ¿Çâ ¹× ¹Ì·¡

ÁÖÃÖ±â°ü : »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ
´ã´çÀÚ : ±èº¸¶ó
¿¬¶ôó : 02-508-7435  

À̸ÞÀÏ : ksbmb5@ksbmb.or.kr

±³À°Á¾·ù : »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 160,000¿ø  

ºñ°í »çÀüµî·Ï: Çлýȸ¿ø 70,000¿ø Á¤È¸¿ø 100,000¿ø Çлý ºñȸ¿ø 100,000¿ø ÀÏ¹Ý ºñȸ¿ø 130,000¿ø /ÇöÀåµî·Ï: Çлýȸ¿ø 100,000¿ø Á¤È¸¿ø 130,000¿ø Çлý ºñȸ¿ø 130,000¿ø ÀÏ¹Ý ºñȸ¿ø 160,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 08¿ù 24ÀÏ ´ë°­´ç 10:30~11:00 Diversified formats of therapeutic antibody : Beyond the classical IgG molecule Á¤ÁØÈ£(¼­¿ï´ë)

±³À°½Ã°£ 08¿ù 24ÀÏ ´ë°­´ç 11:00~11:30 Unlocking the Full Potential of IgG Antibodies: Fc Variants Engineered for a Variety of Desired Functions Á¤»óÅÃ(°í·Á´ë)

±³À°½Ã°£ 08¿ù 24ÀÏ ´ë°­´ç 11:30~12:00 Cancer immunotherapy with ​bispecific T-cell engager À̽¿ì(POSTECH)

±³À°½Ã°£ 08¿ù 24ÀÏ ´ë°­´ç 12:00~12:30 Development strategy and trend of innovative antibody therapeutics À¯¿ø±Ô(¿¡À̺ñ¿¤¹ÙÀÌ¿À¢ß)

½Ä»ç 08¿ù 24ÀÏ Çлý½Ä´ç 12:30~13:30 Lunch ()

±³À°½Ã°£ 08¿ù 24ÀÏ ´ë°­´ç 13:30~14:00 Stem cell-based therapy of cardiovascular diseases ±èÀçÈ£(ºÎ»ê´ë)

±³À°½Ã°£ 08¿ù 24ÀÏ ´ë°­´ç 14:00~14:30 Platform development for CAR-NK therapy ±èŵ·(KRIBB)

±³À°½Ã°£ 08¿ù 24ÀÏ ´ë°­´ç 14:30~15:00 Current status of CAR-T cell Therapy ±èÂùÇõ(KAIST)

±³À°½Ã°£ 08¿ù 24ÀÏ ´ë°­´ç 15:00~15:30 Human pluripotent stem cell-derived intestinal organoid and its applications ¼Õ¹Ì¿µ(KRIBB)

ÈÞ½Ä 08¿ù 24ÀÏ ´ë°­´ç 15:30~15:45 Break ()

±³À°½Ã°£ 08¿ù 24ÀÏ ´ë°­´ç 15:45~16:15 Current strategies for developing mRNA vaccine platform ÃÖÁØÈ£(ÇѾç´ë)

±³À°½Ã°£ 08¿ù 24ÀÏ ´ë°­´ç 16:15~16:45 Therapeutic Strategies for Hearing Loss ÁöÇ念(¿¬¼¼´ë)

±³À°½Ã°£ 08¿ù 24ÀÏ ´ë°­´ç 16:45~17:15 Exosome-based delivery of therapeutic proteins: from the bench to the clinic ÃÖöÈñ((ÁÖ)Àϸ®¾Æ½º¹ÙÀÌ¿À·ÎÁ÷½º)

±³À°½Ã°£ 08¿ù 24ÀÏ ´ë°­´ç 17:15~17:45 Exosome-Based Delivery of Proteins withTherapeuticPotentials: from the bench to the clinic °í¿ë¼Û(POSTECH/(ÁÖ)·ÎÁ¦Å¸¿¢¼ÒÁ»)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦ 26ȸ »ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿¬¼ö°­ÁÂ: ¹ÙÀÌ¿À Ä¡·áÁ¦ÀÇ µ¿Çâ ¹× ¹Ì·¡ : 2023-08-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û [¿Â¶óÀÎ] 2023 ´ëÇÑÇ÷¾×ÇÐȸ ºÐ±âÁý´ãȸ : 2023-08-24
´ÙÀ½±Û ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2023 Áöȸ½ÉÆ÷Áö¾ö-¼­¿ï(°­¼­) : 2023-08-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20507 ºÎ»ê ´ëÇÑÁ¤Çü¿Ü°ú ºÎ»ê․¿ï»ê․°æ³²Áöȸ Á¦361Â÷ ¿ù·ÊÇмúȸ : 2024-05-14 0 94 2024-04-29
20506 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-¼­¿ï(°­³²) : 2024-05-14 0 121 2024-04-29
20505 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø Æó ¿¬¼ö°­Á : 2024-05-14 0 117 2024-04-29
20504 ¼­¿ï (1ÀÏÂ÷) ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2024³â Ãá°è½ÉÆ÷Áö¾ö : 2024-05-13 0 66 2024-04-29
20503 ´ëÀü Çѱ¹¿©ÀÚÀÇ»çȸ ´ëÀüÁöȸ 5¿ù Çмú½ÉÆ÷Áö¾ö(¾î±ú ÅëÁõÀÇ ¿øÀΰú Ä¡·á) : 2024-05-13 0 56 2024-04-29
20502 °æ±â (¿Â¶óÀÎ) Á¦1Â÷ ±ºÆ÷½ÃÀÇ»çȸ Çмú´ëȸ : 2024-05-12 0 115 2024-04-29
20501 ¼­¿ï Á¦12ȸ ´ëÇÑÀÓ»ó¼øȯ±âÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-12 0 72 2024-04-29
20500 ¼­¿ï 2024 Á¦2Â÷ ´ëÇÑ»êºÎÀΰú³»ºÐºñÇÐȸºÎÀοµ»ó¿¬±¸ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-05-12 0 79 2024-04-29
20499 ¼­¿ï Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥ : 2024-05-11 0 120 2024-04-29
20498 ºÎ»ê ¸¸¼ºÆó¼â °ü»óµ¿¸Æ ÁßÀç½Ã¼ú¿¬±¸È¸ The 23rd K-CTO(Korean Chronic Total Occlusion Club) Live Demonstration : 2024-05-11 0 80 2024-04-29
20497 ¼­¿ï ´ëÇÑÀü¸³¼±ÇÐȸ The 3rd Korean Prostate Society Prostate Cancer Working Group Symposium : 2024-05-11 0 143 2024-04-29
20496 ¼­¿ï 2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-11 0 56 2024-04-29
20495 ¼­¿ï Á¦77Â÷ ´ëÇÑû°¢ÇÐȸ Çмú´ëȸ : 2024-05-11 0 111 2024-04-29
20494 ÀÎõ Á¦9ȸ °¡Ãµ´ë ±æº´¿ø ½Å°æ¿Ü°ú ¾÷µ¥ÀÌÆ® ½ÉÆ÷Áö¿ò (G-NeUS) : 2024-05-11 0 107 2024-04-29
20493 ´ëÀü 2024³â ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ Ãá°èÇмú´ëȸ & Basic Training Course : 2024-05-11 0 89 2024-04-29
41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷